Hello, Fool! | Login | Signup | My Fool
Oct 15, 2008 6:26 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.
View All Commentary (PGNX)
Recs
tenmiles (99.99) Submitted: 4/11/07 4:20 PM : Start Price: $25.48 PGNX Score: -22.99
Company's primary drug competitor just suffered FDA setback, providing PGNX huge "early provider" advantage
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK